These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3437613)

  • 1. A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):255-60. PubMed ID: 3437613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of maprotiline and its adverse effects on depressed patients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):247-54. PubMed ID: 3437612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood concentrations of maprotiline in depressive patients].
    Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
    Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
    Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
    Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
    Hrdina PD; Lapierre YD
    Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLC-mass spectrometric determination of maprotiline and its major metabolite using stable isotope-labeled analog as internal standard.
    Jindal SP; Lutz T; Vestergaard P
    J Pharm Sci; 1980 Jun; 69(6):684-7. PubMed ID: 7205583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography.
    Yufu N; Itoh M; Notomi A; Nakao H
    Folia Psychiatr Neurol Jpn; 1984; 38(1):57-64. PubMed ID: 6537393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of maprotiline in serum by gas-chromatography, with use of a nitrogen-specific detector.
    Gupta RN; Molnar G; Gupta ML
    Clin Chem; 1977 Oct; 23(10):1849-52. PubMed ID: 902409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatographic analysis of therapeutic concentrations of maprotiline in serum, using flame-ionization detection.
    Kärkkäinen S; Seppälä E
    J Chromatogr; 1980 Dec; 221(2):319-26. PubMed ID: 7217301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
    Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
    Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures associated with high maprotiline serum concentrations.
    Molnar G
    Can J Psychiatry; 1983 Nov; 28(7):555-6. PubMed ID: 6418369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
    Kuss HJ; Feistenauer E
    J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of maprotiline and desmethylmaprotiline in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
    Drebit R; Baker GB; Dewhurst WG
    J Chromatogr; 1988 Nov; 432():334-9. PubMed ID: 3220903
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatographic determination of maprotiline and its N-desmethyl metabolite in human blood using nitrogen detection.
    Sioufi A; Richard A
    J Chromatogr; 1980 Dec; 221(2):393-8. PubMed ID: 7217308
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic effect of maprotiline and chlorimipramine: controlled study.
    Montejo-Iglesias ML; Ramos-Brieva JA
    Neuropsychobiology; 1988; 19(1):20-4. PubMed ID: 3054622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.